Literature DB >> 19836860

Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach.

Ashraf H Abadi1, Dalal A Abouel-Ella, Jochen Lehmann, Heather N Tinsley, Bernard D Gary, Gary A Piazza, Mohammed A O Abdel-Fattah.   

Abstract

Two series with the general formula of 4,6-diaryl-2-oxo-1,2 dihydropyridine-3-carbonitriles and their isosteric 4,6-diaryl-2-imino-1,2-dihydropyridine-3-carbonitrile were synthesized through one pot reaction of the appropriate acetophenone, aldehyde, ammonium acetate with ethyl cyanoacetate or malononitrile, respectively. The synthesized compounds were evaluated for their tumor cell growth inhibitory activity against the human HT-29 colon tumor cell line, as well as their PDE3 inhibitory activity. Compound 4-(2-Ethoxyphenyl)-2-oxo-6-thiophen-3-yl-1,2-dihydropyridine-3 carbonitrile (21) showed tumor cell growth inhibitory activity with an IC50 value of 1.25 microM. Meanwhile, 4-(4-Ethoxyphenyl)-2-imino-6-(thiophen-3-yl)-1,2-dihydropyridine-3-carbonitrile (26) showed inhibitory effect upon PDE3 using cAMP or cGMP as substrate. No correlation exists between PDE3 inhibition and the tumor cell growth inhibitory activity. Docking compound 21 to other possible molecular targets showed the potential to bind PIM1 Kinase. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19836860      PMCID: PMC4980843          DOI: 10.1016/j.ejmech.2009.09.029

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  14 in total

1.  Phosphodiesterase 3 as a potential target for therapy of malignant tumors in the submandibular gland.

Authors:  T Murata; T Sugatani; K Shimizu; V C Manganiello; T Tagawa
Journal:  Anticancer Drugs       Date:  2001-01       Impact factor: 2.248

2.  Expression and role of phosphodiesterase 3 in human squamous cell carcinoma KB cells.

Authors:  Kasumi Shimizu; Taku Murata; Kenya Okumura; Vincent C Manganiello; Toshiro Tagawa
Journal:  Anticancer Drugs       Date:  2002-09       Impact factor: 2.248

3.  Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.

Authors:  Stuart J Netherton; Donald H Maurice
Journal:  Mol Pharmacol       Date:  2004-10-08       Impact factor: 4.436

Review 4.  Re-discovering PDE3 inhibitors--new opportunities for a long neglected target.

Authors:  Philip E Thompson; Vincent Manganiello; Eva Degerman
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

5.  Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase.

Authors:  I Wayne Cheney; Shunqi Yan; Todd Appleby; Heli Walker; Todd Vo; Nanhua Yao; Robert Hamatake; Zhi Hong; Jim Z Wu
Journal:  Bioorg Med Chem Lett       Date:  2007-01-04       Impact factor: 2.823

6.  Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.

Authors:  Eunyi Moon; Richard Lee; Richard Near; Lewis Weintraub; Sharon Wolda; Adam Lerner
Journal:  Clin Cancer Res       Date:  2002-02       Impact factor: 12.531

7.  Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.

Authors:  W Velando Rankin; C J Henry; S E Turnquist; J R Turk; M E Beissenherz; J W Tyler; E B Rucker; D W Knapp; C O Rodriguez; J A Green
Journal:  Vet Comp Oncol       Date:  2008-09       Impact factor: 2.613

8.  Reduced DNA synthesis and cell viability in small cell lung carcinoma by treatment with cyclic AMP phosphodiesterase inhibitors.

Authors:  S H Shafer; S H Phelps; C L Williams
Journal:  Biochem Pharmacol       Date:  1998-11-01       Impact factor: 5.858

9.  Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival.

Authors:  Clark M Whitehead; Keith A Earle; John Fetter; Songmei Xu; Theresa Hartman; Daniel C Chan; Tom L M Zhao; Gary Piazza; Andres J P Klein-Szanto; Rifat Pamukcu; Hector Alila; Paul A Bunn; W Joseph Thompson
Journal:  Mol Cancer Ther       Date:  2003-05       Impact factor: 6.261

10.  Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling.

Authors:  Yunsong Tong; Kent D Stewart; Sheela Thomas; Magdalena Przytulinska; Eric F Johnson; Vered Klinghofer; Joel Leverson; Owen McCall; Niru B Soni; Yan Luo; Nan-horng Lin; Thomas J Sowin; Vincent L Giranda; Thomas D Penning
Journal:  Bioorg Med Chem Lett       Date:  2008-08-28       Impact factor: 2.823

View more
  13 in total

1.  CoMFA and CoMSIA studies of 1,2-dihydropyridine derivatives as anticancer agents.

Authors:  Ismail Salama; Mohamed A O Abdel-Fattah; Marwa S Hany; Shaimaa A El-Sharif; Mahmoud A M El-Naggar; Rasha M H Rashied; Gary A Piazza; Ashraf H Abadi
Journal:  Med Chem       Date:  2012-05       Impact factor: 2.745

2.  Four-component synthesis of 1,2-dihydropyridine derivatives and their evaluation as anticancer agents.

Authors:  Mohamed A O Abdel-Fattah; Mahmoud A M El-Naggar; Rasha M H Rashied; Bernard D Gary; Gary A Piazza; Ashraf H Abadi
Journal:  Med Chem       Date:  2012-05       Impact factor: 2.745

3.  Modulating the cyclic guanosine monophosphate substrate selectivity of the phosphodiesterase 3 inhibitors by pyridine, pyrido[2,3-d]pyrimidine derivatives and their effects upon the growth of HT-29 cancer cell line.

Authors:  Ashraf Hassan Abadi; Marwa Saeed Hany; Shimaa Awadain Elsharif; Amal Abdel Haleem Eissa; Bernard Dewayne Gary; Heather Nicole Tinsley; Gary Anthony Piazza
Journal:  Chem Pharm Bull (Tokyo)       Date:  2013       Impact factor: 1.645

4.  Click-Engineered, Bioresponsive, and Versatile Particle-Protein-Dye System.

Authors:  Mary K Burdette; Ragini Jenkins; Yuriy P Bandera; Haley Jones; Isabell K Foulger; Ashley Dickey; Anna-Liisa Nieminen; Stephen H Foulger
Journal:  ACS Appl Bio Mater       Date:  2019-07-01

Review 5.  Synthesis of Biologically Active Molecules through Multicomponent Reactions.

Authors:  Daniel Insuasty; Juan Castillo; Diana Becerra; Hugo Rojas; Rodrigo Abonia
Journal:  Molecules       Date:  2020-01-24       Impact factor: 4.411

Review 6.  Plant ubiquitin-proteasome pathway and its role in gibberellin signaling.

Authors:  Feng Wang; Xing Wang Deng
Journal:  Cell Res       Date:  2011-07-26       Impact factor: 46.297

Review 7.  PIM1: a promising target in patients with triple-negative breast cancer.

Authors:  Wen Zhao; RuiYue Qiu; Pan Li; Jin Yang
Journal:  Med Oncol       Date:  2017-07-18       Impact factor: 3.064

8.  Novel Therapeutics: NSAIDs, Derivatives, and Phosphodiesterases.

Authors:  Heather N Tinsley; Gary A Piazza
Journal:  Curr Colorectal Cancer Rep       Date:  2012-12

9.  Synthesis of some dihydropyrimidine-based compounds bearing pyrazoline moiety and evaluation of their antiproliferative activity.

Authors:  Fadi M Awadallah; Gary A Piazza; Bernard D Gary; Adam B Keeton; Joshua C Canzoneri
Journal:  Eur J Med Chem       Date:  2013-10-09       Impact factor: 6.514

10.  Sequestering survivin to functionalized nanoparticles: a strategy to enhance apoptosis in cancer cells.

Authors:  Ragini Jenkins; Yuriy P Bandera; Michael A Daniele; LeAnna L Ledford; Ashlee Tietje; Andrew A Kelso; Michael G Sehorn; Yanzhang Wei; Mrinmay Chakrabarti; Swapan K Ray; Stephen H Foulger
Journal:  Biomater Sci       Date:  2016-02-04       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.